scholarly article | Q13442814 |
P2093 | author name string | Nalini S Shah | |
Tushar R Bandgar | |||
Hina Shah | |||
Gaurav Malhotra | |||
Vikram R Lele | |||
Priya Hira | |||
Vijaya Sarathi | |||
Anurag Lila | |||
Swati Jadhav | |||
Manjunath R Goroshi | |||
Virendra A Patil | |||
P2860 | cites work | Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia. | Q51320250 |
Preoperative assessment of the pancreas in multiple endocrine neoplasia type 1. | Q51356001 | ||
Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India. | Q52984755 | ||
Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1). | Q52992707 | ||
¹⁸F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study. | Q53058863 | ||
Comparison of the prognostic values of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in patients with well-differentiated neuroendocrine tumor. | Q53059695 | ||
68Ga-DOTATOC PET/CT of neuroendocrine tumors: spotlight on the CT phases of a triple-phase protocol. | Q53083280 | ||
Thymic Neuroendocrine Neoplasms: Biological Behaviour and Therapy. | Q53637052 | ||
Somatostatin Receptor Imaging with68Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in Interpretation | Q57758753 | ||
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes | Q24603675 | ||
Radiological surveillance in multiple endocrine neoplasia type 1: a double-edged sword? | Q33656493 | ||
Guidelines for diagnosis and therapy of MEN type 1 and type 2. | Q34104591 | ||
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). | Q34283436 | ||
A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. | Q34650336 | ||
Results of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1. | Q35891227 | ||
Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis | Q37986605 | ||
Neuroendocrine tumours: the role of imaging for diagnosis and therapy | Q38169928 | ||
The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. | Q38243866 | ||
Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - Imaging and staging | Q38772470 | ||
Focused parathyroidectomy without intraoperative parathormone testing is safe after pre-operative localization with 18F-Fluorocholine PET/CT. | Q38989715 | ||
Management impact: effects on quality of life and prognosis in MEN1. | Q39451392 | ||
Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1. | Q40051095 | ||
Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? | Q40182879 | ||
Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies | Q43066318 | ||
Percentage arterial enhancement: An objective index for accurate identification of parathyroid adenoma/hyperplasia in primary hyperparathyroidism. | Q48213734 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P921 | main subject | computed tomography | Q32566 |
multiple endocrine neoplasia | Q1553018 | ||
P304 | page(s) | 99-105 | |
P577 | publication date | 2020-01-29 | |
P1433 | published in | World Journal of Nuclear Medicine | Q15817346 |
P1476 | title | Comparison of 68Ga-DOTA-NaI3-Octreotide/tyr3-octreotate positron emission tomography/computed tomography and contrast-enhanced computed tomography in localization of tumors in multiple endocrine neoplasia 1 syndrome | |
P478 | volume | 19 |
Search more.